MindRank Announces U.S. FDA Clearance of IND Application for M...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SHANGHAI and HANGZHOU, China, Dec. 26, 2022 /PRNewswire-AsiaNet/ -- MindRank, an artificial intelligence (AI)-empowered drug discovery company, announces today that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for MDR-001, an oral small-molecule g...
Authors: LATEST ASIANET NEWS RELEASES